HK1032745A1 - Method for developing, testing and using associates of macromolecules and complex aggregates for improved payload and controllable de/association rates. - Google Patents

Method for developing, testing and using associates of macromolecules and complex aggregates for improved payload and controllable de/association rates.

Info

Publication number
HK1032745A1
HK1032745A1 HK01103359A HK01103359A HK1032745A1 HK 1032745 A1 HK1032745 A1 HK 1032745A1 HK 01103359 A HK01103359 A HK 01103359A HK 01103359 A HK01103359 A HK 01103359A HK 1032745 A1 HK1032745 A1 HK 1032745A1
Authority
HK
Hong Kong
Prior art keywords
macromolecules
associates
controllable
developing
testing
Prior art date
Application number
HK01103359A
Other languages
English (en)
Inventor
Gregor Cevc
Original Assignee
Idea Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idea Ag filed Critical Idea Ag
Publication of HK1032745A1 publication Critical patent/HK1032745A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
HK01103359A 1998-10-23 2001-05-15 Method for developing, testing and using associates of macromolecules and complex aggregates for improved payload and controllable de/association rates. HK1032745A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP1998/006750 WO2000024377A1 (en) 1998-10-23 1998-10-23 Method for developing, testing and using associates of macromolecules and complex aggregates for improved payload and controllable de/association rates

Publications (1)

Publication Number Publication Date
HK1032745A1 true HK1032745A1 (en) 2001-08-03

Family

ID=8167110

Family Applications (1)

Application Number Title Priority Date Filing Date
HK01103359A HK1032745A1 (en) 1998-10-23 2001-05-15 Method for developing, testing and using associates of macromolecules and complex aggregates for improved payload and controllable de/association rates.

Country Status (13)

Country Link
US (2) US20080311184A1 (zh)
EP (1) EP1039880A1 (zh)
JP (1) JP4838936B2 (zh)
KR (1) KR100464601B1 (zh)
CN (1) CN1192766C (zh)
AU (1) AU765385C (zh)
BR (1) BR9814415A (zh)
CA (1) CA2309633C (zh)
HK (1) HK1032745A1 (zh)
HU (1) HUP0102741A3 (zh)
MX (1) MXPA00006196A (zh)
NO (1) NO20003287L (zh)
WO (1) WO2000024377A1 (zh)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1031346B1 (en) 1999-01-27 2002-05-02 Idea Ag Noninvasive vaccination through the skin
ES2173679T3 (es) 1999-01-27 2002-10-16 Idea Ag Inmunizacion/transporte transnasal con vehiculos altamente adaptables.
US7473432B2 (en) * 2002-10-11 2009-01-06 Idea Ag NSAID formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery
GB2398495B (en) * 2003-01-23 2007-08-22 Kent G Lau A drug delivery preparation comprising at least one anti-tumour drug and a topical carrier for the drug
UA75030C2 (en) * 2005-11-30 2006-03-15 Viktor Oleksandrovych Bykov Method for obtaining stable aqueous solutions of drugs
GB0623838D0 (en) * 2006-11-29 2007-01-10 Malvern Cosmeceutics Ltd Novel compositions
US8962015B2 (en) 2007-09-28 2015-02-24 Sdg, Inc. Orally bioavailable lipid-based constructs
WO2012006956A1 (zh) * 2010-07-14 2012-01-19 中国医学科学院药物研究所 一种胰岛素的脂质复合物及其制备方法和制剂
US8422540B1 (en) 2012-06-21 2013-04-16 CBF Networks, Inc. Intelligent backhaul radio with zero division duplexing
KR101849441B1 (ko) 2015-03-19 2018-04-16 김태구 캔 오프너
KR20160112915A (ko) 2015-10-23 2016-09-28 김태구 캔 오프너
WO2017087685A1 (en) * 2015-11-20 2017-05-26 The Regents Of The University Of California Deformable nano-scale vehicles (dnvs) for trans-blood brain barrier, trans-mucosal, and transdermal drug delivery
WO2018169954A1 (en) * 2017-03-13 2018-09-20 Sdg, Inc. Lipid-based nanoparticles with enhanced stability
AU2018331357A1 (en) 2017-09-18 2020-04-02 Bayer Healthcare Llc Methods of inactivation of viruses using N-methylglucamides and its Derivatives
CN112533478A (zh) * 2018-08-08 2021-03-19 3M创新有限公司 治疗组合物和相关方法
KR20220118210A (ko) * 2021-02-18 2022-08-25 (주)아모레퍼시픽 트랜스퍼좀을 포함하는 난용성 효능물질 전달체
CN115350330B (zh) * 2022-09-01 2023-10-20 北京化工大学 一种负电性小分子调控的表面在蛋白差异性黏附上的应用

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL64397A0 (en) * 1981-01-07 1982-02-28 Weder Hans G Process for the preparation of liposomal medicaments
US5008050A (en) * 1984-06-20 1991-04-16 The Liposome Company, Inc. Extrusion technique for producing unilamellar vesicles
US4897269A (en) * 1984-09-24 1990-01-30 Mezei Associates Limited Administration of drugs with multiphase liposomal delivery system
US4937182A (en) * 1985-12-19 1990-06-26 Peralta Cancer Research Institute Method for predicting chemosensitivity of anti-cancer drugs
US5244678A (en) * 1986-01-14 1993-09-14 Ire-Celltarg S.A. Pharmaceutical composition containing a local anesthetic and/or centrally acting analgesic encapsulated in liposomes
EP0293465B1 (en) * 1986-11-28 1992-03-18 The Liposome Company, Inc. Phospholipid composition
US4849224A (en) * 1987-11-12 1989-07-18 Theratech Inc. Device for administering an active agent to the skin or mucosa
US5043165A (en) * 1988-12-14 1991-08-27 Liposome Technology, Inc. Novel liposome composition for sustained release of steroidal drugs
US5049392A (en) * 1989-01-18 1991-09-17 The Liposome Company, Inc. Osmotically dependent vesicles
EP0384040B1 (en) * 1989-02-24 1994-01-26 Agfa-Gevaert N.V. Dye-donor element for thermal dye sublimation transfer
US5580575A (en) * 1989-12-22 1996-12-03 Imarx Pharmaceutical Corp. Therapeutic drug delivery systems
CA2067754C (en) * 1990-08-24 2002-06-04 Gregor Cevc Preparation for the application of agents in mini-droplets
US5202125A (en) * 1990-12-10 1993-04-13 Theratech, Inc. Method and systems for administering nitroglycerin transdermally at enhanced transdermal fluxes
JP2922017B2 (ja) * 1991-03-25 1999-07-19 第一製薬株式会社 経口用脂質膜構造体
US5498420A (en) * 1991-04-12 1996-03-12 Merz & Co. Gmbh & Co. Stable small particle liposome preparations, their production and use in topical cosmetic, and pharmaceutical compositions
HU223343B1 (hu) * 1991-05-20 2004-06-28 Novartis Ag. Allil-amin-származékot tartalmazó gyógyászati készítmények és eljárás azok előállítására
GB9116610D0 (en) * 1991-08-01 1991-09-18 Danbiosyst Uk Preparation of microparticles
EG20380A (en) * 1991-10-16 1999-02-28 Richardson Vicks Inc Enhanced skin penetration system for improved topical delivery of drugs
AU675211B2 (en) * 1991-10-16 1997-01-30 Richardson-Vicks Inc. Enhanced skin penetration system for improved topical delivery of drugs
JPH08509202A (ja) * 1992-07-08 1996-10-01 ディアノルム―ゲレーテ・ゲー・マイエルホファー・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング リポソーム、それを調製する方法及び薬調製におけるその用途
DE69310518T2 (de) * 1992-07-28 1997-10-02 Procter & Gamble Pharmazeutische zusammensetzung zur topischen anwendung die ein vernetztes kationisches polymer und einen alkoxylierte äther enthält
US5460820B1 (en) * 1993-08-03 1999-08-03 Theratech Inc Method for providing testosterone and optionally estrogen replacement therapy to women
AU3559695A (en) * 1994-09-30 1996-04-26 Inex Pharmaceuticals Corp. Glycosylated protein-liposome conjugates and methods for their preparation
DE69532622T2 (de) * 1994-12-07 2005-02-03 Tokyo Cosmos Electric Co. Ltd., , Hachioji Flächenheizelement zur Verwendung bei Spiegeln
DE4447287C1 (de) * 1994-12-30 1996-11-07 Cevc Gregor Präparat zum Wirkstofftransport durch Barrieren
US5654337A (en) * 1995-03-24 1997-08-05 II William Scott Snyder Topical formulation for local delivery of a pharmaceutically active agent
US5783208A (en) * 1996-07-19 1998-07-21 Theratech, Inc. Transdermal drug delivery matrix for coadministering estradiol and another steroid
US5891472A (en) * 1996-11-19 1999-04-06 Meri Charmyne Russell Treatment of equine laminitis
US5891467A (en) * 1997-01-31 1999-04-06 Depotech Corporation Method for utilizing neutral lipids to modify in vivo release from multivesicular liposomes
US6726925B1 (en) * 1998-06-18 2004-04-27 Duke University Temperature-sensitive liposomal formulation
CN1320880C (zh) * 1998-12-23 2007-06-13 伊迪亚股份公司 改进的体内局部无创伤用制剂
MXPA02000053A (es) * 1999-07-05 2003-07-21 Idea Ag Un metodo para mejorar el tratamiento a traves de barreras adaptables semipermeables.
US6562370B2 (en) * 1999-12-16 2003-05-13 Dermatrends, Inc. Transdermal administration of steroid drugs using hydroxide-releasing agents as permeation enhancers
JP2002063747A (ja) * 2000-08-18 2002-02-28 Sony Corp 記録媒体および記録媒体原盤ならびに記録媒体の製造方法
US7473432B2 (en) * 2002-10-11 2009-01-06 Idea Ag NSAID formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery
GB0417494D0 (en) * 2004-08-05 2004-09-08 Glaxosmithkline Biolog Sa Vaccine

Also Published As

Publication number Publication date
AU1435099A (en) 2000-05-15
US20080311184A1 (en) 2008-12-18
NO20003287L (no) 2000-08-23
CA2309633C (en) 2010-12-14
JP4838936B2 (ja) 2011-12-14
KR20010033518A (ko) 2001-04-25
AU765385B2 (en) 2003-09-18
CA2309633A1 (en) 2000-05-04
EP1039880A1 (en) 2000-10-04
BR9814415A (pt) 2000-10-10
CN1283107A (zh) 2001-02-07
NO20003287D0 (no) 2000-06-22
HUP0102741A3 (en) 2002-12-28
AU765385C (en) 2004-05-20
WO2000024377A1 (en) 2000-05-04
HUP0102741A2 (hu) 2002-03-28
CN1192766C (zh) 2005-03-16
KR100464601B1 (ko) 2004-12-31
MXPA00006196A (es) 2003-07-21
US20080279815A1 (en) 2008-11-13
JP2002528406A (ja) 2002-09-03

Similar Documents

Publication Publication Date Title
HK1032745A1 (en) Method for developing, testing and using associates of macromolecules and complex aggregates for improved payload and controllable de/association rates.
AU5447499A (en) Exposure apparatus and exposure method, and device and method for producing the same
AU3640799A (en) Apparatus and method for trusted network security
GB2340950B (en) Method and apparatus for automotive and other testing
AU2549899A (en) Method and apparatus for exposure, method of manufacture of exposure tool, device, and method of manufacture of device
HK1036853A1 (en) Method and apparatus for an improved interface between components
SG81984A1 (en) System, apparatus and method for multi-carrier transmission
AU2488299A (en) Method and apparatus for jitter analysis
HK1040285A1 (en) Method and apparatus for testing poles.
AU3267999A (en) Nqr testing method and apparatus
HK1046572A1 (en) Method and apparatus for detecting time domains ona communication channel.
AU5117899A (en) Device and method for authorized funds transfer
GB2353601B (en) Method and apparatus for automotive and other testing
AU6237299A (en) Method and apparatus for location based intercept
AU2889299A (en) Formation testing apparatus and method
AU4461901A (en) Method and apparatus for measurement, and method and apparatus for exposure
EP1248160B8 (en) Developing device, charging method used therefor, and printing apparatus having the developing device
AU3028100A (en) Method and apparatus for masking cryptographic operations
SG86357A1 (en) Method and apparatus for unlatching an actuator
AU3054999A (en) Method and apparatus for wafer processing, and method and apparatus for exposure
AU4221799A (en) System, method and apparatus for purging fluid
AU5066799A (en) Method and apparatus for scanning exposure, and micro device
ZA200200269B (en) Apparatus for and method of testing software applications.
AU7328100A (en) Document, method of its preparation and apparatus for authenticating it
GB2358062B (en) Contents measuring system, method and apparatus

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20121023